Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Details for Australian Patent Application No. 2005313813 (hide)

Owner Virochem Pharma Inc.

Inventors Courchesne, Marc; Bubenik, Monica; Chan Chun Kong, Laval; Vaillancourt, Louis; Moinet, Christophe; Blais, Charles

Agent Griffith Hack

Pub. Number AU-B-2005313813

PCT Pub. Number WO2006/060919

Priority 60/693,051 23.06.05 US; 60/634,266 09.12.04 US

Filing date 9 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 14 April 2011

International Classifications

C07D 471/20 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/060919 Priority application(s): WO2006/060919

14 April 2011 Application Accepted

  Published as AU-B-2005313813

11 August 2011 Standard Patent Sealed

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313814-Novel uses of EGF

2005313797-Signal peptides, nucleic acid molecules and methods of treatment